New treatment reduces heart scarring and abnormal heart rhythms, offering a possibility for future therapies
In a study led by Baylor College of Medicine and the University of Oxford, researchers found that blocking a specific molecular interaction reduced atrial fibrosis in mouse models and cells from human patients with atrial fibrillation (AF), reduced fibrotic responses in human cells, and in the mouse models reversed established atrial fibrosis and reduced abnormal heart rhythms.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
